In 3323 patients with de novo coronary lesions, a sirolimus-eluting balloon with provisional stenting was non-inferior to systematic DES for 1-year target vessel failure (5.3% vs 4.4%) by intention to treat, not per protocol; revascularisation was more frequent (3.3% vs 2.1%).
RCTn = 3,323
Spaulding et al. Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial